Drawing for Serial No. 79012256

USPTO serial 79012256

Serial No. 79012256

Reviewed by CopyMark Law Group

Reg. 3436147Status 404
Filing date
Status date
Registration date
May 27, 2008
Examiner
WHITTAKER BROWN, TRACY
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79012256?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ronni S. Jillions

Ronni S. Jillions Browdy and Neimark, PLLC1625 K St. N.W., Suite 550Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical sets for infusion, drainage, transfusion, administering drugs, dialysis, [ gas supply, ] feeding, [ analysis, ] treatment of diabetes and use in cardiac surgery, consisting primarily of: medical tubes, [ drip counters, bottles, bags, adapters, ] connectors, [ bags, ports, valves. ] Medical products, namely, catheters and catheter systems comprised of catheter tubes, [ guide wires, pressure sensors, fluorometric sensors, temperature sensors, oximetry sensors, magnetic field sensors, piezoelectric sensors, position sensors, glucose sensors, elements for liquor drainage, data loggers, data transmitters, data receivers, microchip components, interfaces to monitors, display screens, monitors, signal cables, power supply lines for the measuring, display, transfer and analysis of physiological parameters, that is parameters of tissue and body fluids, namely, blood, tissue fluid, lymph, urine, cerebrospinal fluid; Diagnostic equipment, namely, analysis device to measure dissolved salts, pH, the risk for urinary stone formation, comprised of measuring heads, medical electrodes, cardiac probes, biofeedback sensors. Precision plastic parts or components manufactured by precision injection moulding for the use in products and instruments for medical purposes in human and veterinary medicine as well as dental medicine, namely, nebulizers for respiration therapy, aerosol atomizers for delivery of drugs into humans and animals, respirators for artificial respiration and accessories for aforesaid nebulizers, atomizers and respirators, containers for the administration of drugs, namely, injection syringe barrels, blood analysis equipment, blood pressure monitoring devices, surgical apparatus and instruments for use in general surgery, dialysis machines, surgical instruments, namely, lavage instruments, medical guide wires, urological equipment and instrumentation, namely, imaging systems, medical screw connectors. Medical bags adapted for and sold with medical, surgical and veterinary instruments, namely, blood bags for transfusion medicine and hematology, transfusion bags, fluid nutrition bags, urine bags. ] Surgical and medical instruments and apparatuses as well as medical equipment for dialysis therapy, namely, [ clamps and/or clasps, bags for medical liquids, pumps, syringes, needles, ] catheters, [ cannulas, plugs, tubes, stents, adapters, ] connectors, [ connections, blood filters and blood bags for transfusion medicine and hematology, ] equipment and disposable articles for hematology and transfusion medicine, namely, [ transfusion bags, ]tubes and connectors [ ; Equipment for plasmapheresis and accessories, namely, cell separation sets, empty bags, bag compressors, equipment for auto-transfusion and accessories, namely, sets for blood purification and plasma sequestration, containers to collect blood, suction tubes; Equipment for medical purposes for the blood bank with accessories, namely, empty bags, tube clips, storage bags for storing blood, electric equipment for chemical analyses of blood ]SECTION 70 - CANCELLED—
042[ Scientific and food regulatory consulting, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of safe manufacturing and quality assurance for medicine and pharmaceutical products. ] Product development for others in the fields of plastic forming processes, namely, injection molding and extrusion, and in the fields of assembling plastic component, namely, cutting, gluing, welding, printing. Technical medical laboratory services for measuring and testing, namely, carrying out of technical measurements, tests and checks. Material testing and analysis, namely, physical, chemical and biological tests in order to assure product quality and compliance with laws and regulations. Services of a technical or chemical laboratory for measuring and testing, namely, carrying out of chemical analyses, technical measurements, tests and checksSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 6, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Dec 6, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 3, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 3, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 3, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 3, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 3, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 5, 2019INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Feb 10, 2019INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 10, 2019INPCINVALIDATION PROCESSED—
Feb 7, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 7, 2018NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 7, 201871AGREGISTERED-SEC.71 ACCEPTED—
May 29, 2018ES71TEAS SECTION 71 RECEIVED—
May 27, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 30, 2015ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 16, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Jun 16, 2014C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Jun 16, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 5, 2014RNWLINTERNATIONAL REGISTRATION RENEWED—
May 23, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Feb 28, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 29, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 11, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 11, 2008FIMPFINAL DISPOSITION PROCESSED—
Aug 27, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 27, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 11, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2008NPUBNOTICE OF PUBLICATION—
Feb 7, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 22, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 31, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 31, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 26, 2007MAILPAPER RECEIVED—
Dec 22, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Dec 22, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2007FAXXFAX RECEIVED—
Nov 21, 2007CNCFCONTINUATION OF FINAL REFUSAL MAILED—
Nov 21, 2007CNCFACTION CONTINUING A FINAL - COMPLETED—
Nov 21, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Nov 21, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 11, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 11, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 13, 2007MAILPAPER RECEIVED—
Aug 11, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Aug 11, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 10, 2007FAXXFAX RECEIVED—
Jul 12, 2007CFRCSUBSEQUENT FINAL MAILED—
Jul 12, 2007CFRCSUBSEQUENT FINAL MAILED—
Jul 12, 2007CFRCSUBSEQUENT FINAL REFUSAL WRITTEN—
May 24, 2007NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 14, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
May 14, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
May 14, 2007ALIEASSIGNED TO LIE—
Apr 20, 2007MAILPAPER RECEIVED—
Apr 16, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 16, 2007FAXXFAX RECEIVED—
Jan 25, 2007OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jan 11, 2007OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 11, 2007OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 30, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 7, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 3, 2006PGRRPETITION GRANTED - RESPONSE RECEIVED—
Oct 23, 2006APETASSIGNED TO PETITION STAFF—
Oct 4, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 4, 2006PETRPETITION TO REVIVE-RECEIVED—
Oct 4, 2006MAILPAPER RECEIVED—
Sep 29, 2006PETRPETITION TO REVIVE-RECEIVED—
Sep 29, 2006FAXXFAX RECEIVED—
Aug 2, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 2, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 16, 2006ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jan 3, 2006CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 31, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 2, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 17, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2005MAILPAPER RECEIVED—
Sep 9, 2005RFNTREFUSAL PROCESSED BY IB—
Aug 26, 2005IRRFIRREGULARITY ON REFUSAL FROM IB—
Aug 22, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 18, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 17, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2005DOCKASSIGNED TO EXAMINER—
Aug 15, 2005NWAPNEW APPLICATION ENTERED—
Aug 11, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance